Herbal Compound Helps Reduce Tumor Cells in Mice

Research assistant Katie McCullough holds up a mouse for Jake Litvag, 16, to see inside a Washington University lab (AP)
Research assistant Katie McCullough holds up a mouse for Jake Litvag, 16, to see inside a Washington University lab (AP)
TT
20

Herbal Compound Helps Reduce Tumor Cells in Mice

Research assistant Katie McCullough holds up a mouse for Jake Litvag, 16, to see inside a Washington University lab (AP)
Research assistant Katie McCullough holds up a mouse for Jake Litvag, 16, to see inside a Washington University lab (AP)

The active compound in Chinese herbs called emodin, also found in some fruits and vegetables, can reduce colon cancer cells in mice, according to researchers at the University of South Carolina School of Medicine.

Physiologists conducting this study involving mice say this is likely due to emodin's ability to reduce the number of pro-tumor macrophages (a type of immune cell that can promote tumorigenesis). The new study was published by the American Physical Society (APS) ahead of print in the American Journal of Physiology-Gastrointestinal and Liver Physiology.

The researchers studied two groups of mice, one of them was treated with emodin. The results showed that mice treated with emodin "exhibited lower protumorigenic M2-like macrophages in the colon."

The team hope their findings could be used soon in human therapeutics.

Colon cancer is the third most common cancer in men and women, and the third leading cause of cancer-related deaths in the US, according to the US Centers for Disease Control and Prevention. It is expected to cause more than 52,000 deaths in the US in 2022.

According to the American Cancer Society, colon cancer risk factors include obesity, physical inactivity, diets high in red meat, smoking, and alcohol use.

“Approximately 70% of colon cancer cases can be attributed to diet or other lifestyle factors. This study raises hope that daily consumption of fresh fruits and vegetables containing emodin could prevent colon cancer in humans,” said Angela Murphy, co-author of the study from the department of pathology, microbiology, and immunology at the University of South Carolina School of Medicine.



Private European Aerospace Startup Completes 1st Test Flight of Orbital Launch Vehicle

In this photo taken from video provided by Isar Aerospace, Photo Wingmen Media, Isar Aerospace test rocket "Spectrum" explodes felling back down after the launch at Andoya Spaceport in Nordmela, on Andøya island, Norway, Sunday, March 30, 2025. (Isar Aerospace, Photo Wingmen Media via AP)
In this photo taken from video provided by Isar Aerospace, Photo Wingmen Media, Isar Aerospace test rocket "Spectrum" explodes felling back down after the launch at Andoya Spaceport in Nordmela, on Andøya island, Norway, Sunday, March 30, 2025. (Isar Aerospace, Photo Wingmen Media via AP)
TT
20

Private European Aerospace Startup Completes 1st Test Flight of Orbital Launch Vehicle

In this photo taken from video provided by Isar Aerospace, Photo Wingmen Media, Isar Aerospace test rocket "Spectrum" explodes felling back down after the launch at Andoya Spaceport in Nordmela, on Andøya island, Norway, Sunday, March 30, 2025. (Isar Aerospace, Photo Wingmen Media via AP)
In this photo taken from video provided by Isar Aerospace, Photo Wingmen Media, Isar Aerospace test rocket "Spectrum" explodes felling back down after the launch at Andoya Spaceport in Nordmela, on Andøya island, Norway, Sunday, March 30, 2025. (Isar Aerospace, Photo Wingmen Media via AP)

A rocket by a private European aerospace company launched from Norway on Sunday and crashed into the sea 30 seconds later.
Despite the short test flight, Isar Aerospace said that it successfully completed the first test flight of its orbital launch vehicle by launching its Spectrum rocket from the island of Andøya in northern Norway.
The 28-meter-long (92-foot-long) Spectrum is a two-stage launch vehicle specifically designed to put small and medium satellites into orbit. The rocket lifted off from the pad at 12:30 p.m. (1030 GMT) Sunday and flew for about a half-minute before the flight was terminated, The Associated Press quoted Isar as saying.
“This allowed the company to gather a substantial amount of flight data and experience to apply on future missions,” Isar said in a statement. “After the flight was terminated at T+30 seconds, the launch vehicle fell into the sea in a controlled manner.”
Video from the launch shows the rocket taking off from the pad, flying into the air and then coming back down to crash into the sea in a fiery explosion.
The launch was subject to various factors, including weather and safety, and Sunday's liftoff followed a week of poor conditions, including a scrubbed launch on March 24 because of unfavorable winds, and on Saturday for weather restrictions.
“Our first test flight met all our expectations, achieving a great success,” Daniel Metzler, Isar’s chief executive and co-founder, said in the statement. “We had a clean liftoff, 30 seconds of flight and even got to validate our Flight Termination System.”
The company had largely ruled out the possibility of the rocket reaching orbit on its first complete flight, saying that it would consider a 30-second flight a success. Isar Aerospace aims to collect as much data and experience as possible on the first integrated test of all the systems on its in-house-developed launch vehicle.
Isar Aerospace is separate from the European Space Agency, or ESA, which is funded by its 23 member states.
“Success to get off the pad, and lots of data already obtained. I am sure @isaraerospace will learn a lot," ESA Director General Josef Aschbacher posted on X. "Rocket launch is hard. Never give up, move forward with even more energy!”